- Home
- VTOL vs MYGN Comparison
VTOL vs MYGN Comparison
Compare VTOL & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTOL
- MYGN
- Stock Information
- Founded
- VTOL N/A
- MYGN 1991
- Country
- VTOL United States
- MYGN United States
- Employees
- VTOL N/A
- MYGN N/A
- Industry
- VTOL Transportation Services
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- VTOL Consumer Discretionary
- MYGN Health Care
- Exchange
- VTOL Nasdaq
- MYGN Nasdaq
- Market Cap
- VTOL 858.4M
- MYGN 744.7M
- IPO Year
- VTOL N/A
- MYGN 1995
- Fundamental
- Price
- VTOL $34.77
- MYGN $5.00
- Analyst Decision
- VTOL Strong Buy
- MYGN Hold
- Analyst Count
- VTOL 1
- MYGN 15
- Target Price
- VTOL $50.00
- MYGN $15.14
- AVG Volume (30 Days)
- VTOL 186.2K
- MYGN 1.3M
- Earning Date
- VTOL 08-05-2025
- MYGN 08-05-2025
- Dividend Yield
- VTOL N/A
- MYGN N/A
- EPS Growth
- VTOL 8054.83
- MYGN N/A
- EPS
- VTOL 3.89
- MYGN N/A
- Revenue
- VTOL $1,428,927,000.00
- MYGN $831,300,000.00
- Revenue This Year
- VTOL $10.56
- MYGN N/A
- Revenue Next Year
- VTOL $10.29
- MYGN $6.68
- P/E Ratio
- VTOL $8.99
- MYGN N/A
- Revenue Growth
- VTOL 6.51
- MYGN 7.38
- 52 Week Low
- VTOL $25.11
- MYGN $3.81
- 52 Week High
- VTOL $41.50
- MYGN $29.30
- Technical
- Relative Strength Index (RSI)
- VTOL 68.04
- MYGN 43.78
- Support Level
- VTOL $35.03
- MYGN $4.90
- Resistance Level
- VTOL $36.14
- MYGN $5.83
- Average True Range (ATR)
- VTOL 0.91
- MYGN 0.29
- MACD
- VTOL 0.13
- MYGN -0.02
- Stochastic Oscillator
- VTOL 90.87
- MYGN 10.75
About VTOL Bristow Group Inc.
Bristow Group Inc is the provider of vertical flight solutions. The group provides aviation services to a broad base of offshore energy companies and government entities. Its business comprises three reportable segments: Offshore Energy Services, Government Services, and Other Services. Its customers in Australia, Brazil, Canada, Chile, the Dutch Caribbean, the Falkland Islands, India, Ireland, the Kingdom of Saudi Arabia, Mexico, the Netherlands, Nigeria, Norway, Spain, Suriname, Trinidad, the UK, and the U.S. offshore energy customers use services to transport personnel to, from and between offshore energy installations.
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.